Kendi AT - Search Results

1

Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy.

Jimbo M, Andrews JR, Ahmed ME, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Lowe VJ, Bold MS. Jimbo M, et al. Among authors: kendi at. Prostate. 2022 Jan;82(1):41-48. doi: 10.1002/pros.24246. Epub 2021 Oct 11. Prostate. 2022. PMID: 34633087

2

Role of ¹⁸F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis.

Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, Chareonthaitawee P, Friedman PA, Sohail MR. Mahmood M, et al. Among authors: kendi at. J Nucl Cardiol. 2019 Jun;26(3):958-970. doi: 10.1007/s12350-017-1063-0. Epub 2017 Sep 14. J Nucl Cardiol. 2019. PMID: 28913626

3

Therapy With ¹⁷⁷Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors.

Kendi AT, Halfdanarson TR, Packard A, Dundar A, Subramaniam RM. Kendi AT, et al. AJR Am J Roentgenol. 2019 Aug;213(2):309-317. doi: 10.2214/AJR.19.21123. Epub 2019 Apr 30. AJR Am J Roentgenol. 2019. PMID: 31039017 Review.

4

Stroke detection with 3 different PET tracers.

Dundar A, Bold MS, Agac B, Kendi AT, Friedman SN. Dundar A, et al. Among authors: kendi at. Radiol Case Rep. 2019 Oct 1;14(11):1447-1451. doi: 10.1016/j.radcr.2019.09.005. eCollection 2019 Nov. Radiol Case Rep. 2019. PMID: 31695834 Free PMC article.

5

Whole-body 18-F-FDG-PET in patients with leptomeningeal disease and correlation with MRI.

Panda A, Hintermeister HA, Hunt CH, Kendi AT. Panda A, et al. Among authors: kendi at. Nucl Med Commun. 2021 Feb 1;42(2):205-215. doi: 10.1097/MNM.0000000000001317. Nucl Med Commun. 2021. PMID: 33165256

6

How We Do It: A Multidisciplinary Approach to ¹⁷⁷Lu DOTATATE Peptide Receptor Radionuclide Therapy.

Burkett BJ, Dundar A, Young JR, Packard AT, Johnson GB, Halfdanarson TR, Eiring RA, Gansen DN, Patton CM, Kendi AT. Burkett BJ, et al. Among authors: kendi at. Radiology. 2021 Feb;298(2):261-274. doi: 10.1148/radiol.2020201745. Epub 2020 Nov 24. Radiology. 2021. PMID: 33231532

7

¹⁸F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature.

Young JR, Graham RP, Venkatesh SK, Kendi AT. Young JR, et al. Among authors: kendi at. Abdom Radiol (NY). 2021 Jun;46(6):2604-2609. doi: 10.1007/s00261-021-02968-2. Epub 2021 Feb 8. Abdom Radiol (NY). 2021. PMID: 33555390 Review.

8

Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS.

Ahmed ME, Joshi VB, Badawy M, Pagliaro LC, Karnes RJ, Lowe V, Thorpe MP, Kwon ED, Kendi AT. Ahmed ME, et al. Among authors: kendi at. Clin Genitourin Cancer. 2021 Jun;19(3):223-229. doi: 10.1016/j.clgc.2020.12.009. Epub 2021 Jan 7. Clin Genitourin Cancer. 2021. PMID: 33632570

9

Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy.

Wee CE, Dundar A, Eiring RA, Badawy M, Hobday TJ, Kendi AT, Packard AT, Halfdanarson TR. Wee CE, et al. Among authors: kendi at. J Nucl Med. 2021 Sep 1;62(9):1320. doi: 10.2967/jnumed.121.262048. Epub 2021 Mar 19. J Nucl Med. 2021. PMID: 33741645 Free article. No abstract available.

10

¹⁷⁷Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.

Sanli Y, Simsek DH, Sanli O, Subramaniam RM, Kendi AT. Sanli Y, et al. Among authors: kendi at. Biomedicines. 2021 Apr 15;9(4):430. doi: 10.3390/biomedicines9040430. Biomedicines. 2021. PMID: 33921146 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters